June 20, 2017June 20, 2017

AXIM Obtains More Financing for Its Cannabinoid Therapies for MS and Bowel Diseases

News

AXIM Biotechnologies has secured an additional $4 million in institutional financing to advance clinical trials of its cannabinoid therapies for multiple sclerosis (MS) and irritable bowel syndrome. Some of the ... Read more

November 18, 2016November 18, 2016

AXIM Biotech to Get U.S. Patent Covering All Cannabinoids in Its Chewing Gums

News

AXIM Biotechnologies announced that the United States Patent and Trademark Office (USPTO) will be issuing a patent covering all cannabinoids — both natural and synthetic — used in a chewing ... Read more

CanChew Gum

AXIM Obtains More Financing for Its Cannabinoid Therapies for MS and Bowel Diseases

AXIM Biotech to Get U.S. Patent Covering All Cannabinoids in Its Chewing Gums

Pin It on Pinterest